Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.

Essential reading for all. A reminder that however logical a therapy might be (giving platelets to those with intracranial bleeding and drug-induced platelet dysfunction), it needs to be submitted to scientific assessment ‒ a clinical trial to ensure that it is safe and efficacious. In this case, it was not.

– Beverley J. Hunt